Dr. Marco Dieci received his Master’s degree in Chemistry from the University of Parma in 1995. He brings over 25 years of management experience in the life science industry, specifically in clinical operations management, pharma business development, and market access. He served as CEO at Holostem, Executive Director at the facility of Children Hospital Bambino Gesù in Rome, CEO of Xellbiogene, and Operations Director at MolMed.